Bing

17-Jun-15 Biomarin Pharmaceutical Inc to Discuss Phase 2 Results with BMN 111 Call scheduled for 4:30 pm ET today 15-Jun-15 BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles …
Yahoo New Zealand · 8/15/2015
BillionairesPortfolio.com: The Billionaires Portfolio will be releasing its newest stock pick on Monday 3/4/2013, and I promise that you don’t want miss it. This could be the biggest potential winner I have ever recommended in The Billionaires portfolio.
MARKET DAILY NEWS · 3/1/2013
Shares of BioMarin Pharmaceutical Inc. (BMRN) are up more than 7% this morning after the company said its experimental drug was effective in improving growth in children with achondroplasia, the most common form of human dwarfism. BioMarin said 10 …
Wall Street Pit · 6/18/2015
After opening at $9.54, Nektar Therapeutics dropped to $9.16 for a new 52-week low. By the closing bell, the company's stock was at $9.50 a share for a loss of 7.5%. Falling to a new 52-week low is never fun for company's shareholder, but, depending on …
Equities · 8/25/2015
Kevin Kennedy: Yeah, you know, again, what I’m looking for, typically, is a stock that maybe has gone downhill for a while, but found bottom, but the trend of the company, you know, the news developments and stuff, all of sudden, you know, kick in and it ...
The Money Show · 8/12/2015
In a move that could help the Swiss drug giant diversify its products, Roche is reportedly cobbling together up to $15 billion in financing to make a play for U.S. rare disease treatment maker BioMarin Pharmaceutical (BMRN). A possible combination would ...
Fox Business · ByMatt Egan · 9/19/2013
The stock should run into initial resistance at its 50-day moving average (MA) of $31.53 and subsequent resistance at its 200-day MA of $32.29. In the past 52 weeks, Discovery Communications share prices have been bracketed by a low of $25.11 and a …
Financial News Network Online · ByRobert Cotter · 8/27/2015
Celgene (CELG): Lagging ... but starting to look like Gilead used to look. Biomarin Pharma (BMRN): Testing the March high of $130. These are just some of the names I'm watching. The one thing they have in common is their relationship to the 50-day …
realmoney.thestreet.com · 5/27/2015
U.S. stocks closed lower Thursday, with the Dow Jones Industrial Average hitting a six-month low ... and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Microsoft Corporation (NASDAQ:MSFT) led the Dow lower, shedding 2 percent, while Walt Disney Co.
International Business Times · 8/7/2015
Oil futures soared nearly 9% yesterday – extending the most-powerful three-day price surge since 1990. A downward revision in U.S. crude production data and an apparent willingness by OPEC to talk about production perpetuated a rally that’s added …
Money Morning · 6/26/2015